Literature DB >> 9282244

Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma.

M C McElwain1, R A Modzelewski, W D Yu, D M Russell, C S Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282244     DOI: 10.1016/s0196-0709(97)90022-3

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


× No keyword cloud information.
  6 in total

1.  CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma.

Authors:  Guoan Chen; So Hee Kim; Amanda N King; Lili Zhao; Robert U Simpson; Paul J Christensen; Zhuwen Wang; Dafydd G Thomas; Thomas J Giordano; Lin Lin; Dean E Brenner; David G Beer; Nithya Ramnath
Journal:  Clin Cancer Res       Date:  2010-12-17       Impact factor: 12.531

2.  1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.

Authors:  Yingyu Ma; Wei-Dong Yu; Pamela A Hershberger; Geraldine Flynn; Rui-Xian Kong; Donald L Trump; Candace S Johnson
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

3.  Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol.

Authors:  Yingyu Ma; Wei-Dong Yu; Bing Su; Mukund Seshadri; Wei Luo; Donald L Trump; Candace S Johnson
Journal:  Cancer       Date:  2012-07-25       Impact factor: 6.860

4.  Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.

Authors:  Nithya Ramnath; Ernest Nadal; Chae Kyung Jeon; Juan Sandoval; Justin Colacino; Laura S Rozek; Paul J Christensen; Manel Esteller; David G Beer; So Hee Kim
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

5.  Vitamin D in combination cancer treatment.

Authors:  Yingyu Ma; Donald L Trump; Candace S Johnson
Journal:  J Cancer       Date:  2010-07-15       Impact factor: 4.207

Review 6.  Chemotherapy of prostate cancer: present and future.

Authors:  Donald Trump; Yiu-Keung Lau
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.